All treatments
Treatment
Autogene Cevumeran clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
This study is looking at a new treatment for a type of bladder cancer called muscle-invasive urothelial carcinoma (MIUC). It combines an experimental medicine, autogene cevumeran, with an existing drug, nivolumab, to see if this combination works better and is safe compared to nivolumab alone.
For: Muscle-invasive Urothelial CarcinomaUnited States · Argentina · Australia - RecruitingPHASE2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
This study looks at new treatments for pancreatic cancer after surgery. It compares a new combination of drugs (Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX) with a standard treatment (mFOLFIRINOX alone) to see which works best and is safest for patients with no remaining cancer after their operation.
For: Adenocarcinoma, Pancreatic DuctalUnited States · Belgium · Canada